Genetic, Neurophysiological and Psychological Risk Factors for Neuropathic Pain
Role of Genetic, Neurophysiological and Psychological Factors in the Development of Postsurgical Neuropathic Pain After Breast Surgery for Cancer
1 other identifier
observational
250
1 country
2
Brief Summary
The objective of these cohorts is to detect potential genetic, neurophysiological psychological and cognitive risk factors for the development of chronic postsurgical pain including neuropathic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2015
CompletedFirst Posted
Study publicly available on registry
February 23, 2015
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedApril 30, 2021
April 1, 2021
3.4 years
February 13, 2015
April 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
neuropathic pain
neuropathic pain assessed with the DN4 questionnaire
3, 6 and 12 months after surgery in the prospective cohort
Secondary Outcomes (1)
chronic postsurgical pain
3, 6 and 12 months after surgery
Study Arms (2)
prospective cohort of patients undergoing mastectomy
Prospective cohort
cross sectional cohort of patients
Cross sectional cohort
Eligibility Criteria
The first group of patients consists of women recruited from René Huguenin Hospital (Saint Cloud, Ile de France) for mastectomy or lumpectomy to treat breast cancer, with axillary lymph node dissection in all cases. The second cohort will consist of women already operared of breast surgery in the last 2 years. The third cohort will consist of men or women recruited from Foch hospital (Suresnes, Ile de France) for thoracotomy for cancer.
You may qualify if:
- Patients undergoing surgery for breast cancer or thoracotomy for lung cancer followed during the course of the study or patients from the French cohort Seintinelle already operated from breast surgery over the past 2 years.
You may not qualify if:
- Patients are not included if they have clinically significant or unstable psychiatric or somatic conditions (e.g. major depression, psychosis, uncontrolled diabetes mellitus or hypertension, neurological disorders, immune disease, body mass index \> 45), past or present substance abuse or any cognitive deterioration based on past medical history, semi-structured interview and lack of completion or full understanding of questionnaires.
- Bilateral mastectomy (for women undergoing breast surgery)
- Presence of pain before surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Ambroise Paré Parislead
- Hopital Fochcollaborator
Study Sites (2)
Hôpital Foch
Suresnes, Hauts De Seine, 92, France
Hôpital Ambroise Paré
Boulogne-Billancourt, 92100, France
Related Publications (1)
Sperandio G, Baudic S, Bennedsgaard K, Grosen K, Andersen IS, Finnerup NB, Albi-Feldzer A, Flor H, Nees F, Bouhassira D, Attal N. Somatic and psychological predictors of chronic postsurgical pain in cancer patients: a machine learning approach in a longitudinal two-centre study. Br J Anaesth. 2026 Jan 7:S0007-0912(25)00847-5. doi: 10.1016/j.bja.2025.12.002. Online ahead of print.
PMID: 41506969DERIVED
Biospecimen
The samples will use GWAS to detect potential genetic risk factors for neuropathic pain. These data will be analysed in Oxford laboratory (McCarthy).
Study Officials
- PRINCIPAL INVESTIGATOR
Nadine ATTAL, MD, PhD
Principal Investigator
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 13, 2015
First Posted
February 23, 2015
Study Start
March 1, 2017
Primary Completion
July 30, 2020
Study Completion
September 30, 2020
Last Updated
April 30, 2021
Record last verified: 2021-04